Extrawell Pharmaceutical Holdings Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Extrawell Pharmaceutical Holdings Limited with three other
pharmaceutical manufacturers in Asia:
sales of 851.10 million Indian Rupees [US$11.32 million]
(739.26 million Indian Rupees [US$9.83 million]
of which 69%
was API), and
Coral Laboratories Limited
based in INDIA
(705.80 million Indian Rupees [US$9.39 million]
During the year ended March of 2020, sales at
Extrawell Pharmaceutical Holdings Limited were HK$77.58 million (US$10.01 million).
decrease of 13.0%
versus 2019, when the company's sales were HK$89.22 million.